 |
Since 1939, F-D-C Reports has been helping pharmaceutical
and healthcare executives, policy-makers, and analysts understand the
developments affecting the regulation and marketing of
healthcare products and services in the U.S.
F-D-C Reports has one of the largest, most experienced, and most respected editorial teams reporting on the latest regulatory,
legislative, and business news affecting the U.S. drug, biotechnology, medical
device, nonprescription drug, nutritionals, and cosmetics industries.
|
|
|
